|Bid||0.00 x 1300|
|Ask||121.41 x 800|
|Day's Range||120.00 - 122.44|
|52 Week Range||80.85 - 136.48|
|Beta (5Y Monthly)||1.28|
|PE Ratio (TTM)||16.29|
|Earnings Date||Oct 27, 2021 - Nov 01, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||143.11|
During Nephrology Nurses Week, DaVita Kidney Care begins a new chapter for its nursing program by announcing Tina Livaudais as the kidney care provider's chief nursing officer (CNO). Livaudais most recently served as vice president of clinical services for the national hospital services group, overseeing more than 4,600 DaVita teammates.
There are several healthcare companies in Berkshire Hathaway's portfolio, but only one in its top 10 holdings.
DaVita Inc. announced today that its Board of Directors appointed a new independent director, Gregory Moore, M.D., Ph.D., to join the Board, effective Sept. 9, 2021.